Product Video - Science

Research Behind Stemregen

This video provides an in-depth look at the research supporting Stemregen, emphasizing the rigorous scientific studies that validate the product's impact on stem cell mobilization and tissue repair. It also addresses misconceptions about product testing and highlights ongoing human trials demonstrating the potential of enhancing the body's innate repair system.

Research Behind Stemregen

In this discussion, the speaker clarifies the extensive research foundation behind Stemregen and addresses a common critique: the necessity of testing the exact product formulation to substantiate its claims. Unlike many supplements that rely on studies of loosely related ingredients, Stemregen is composed of the very same extracts used in double-blind, placebo-controlled studies. This ensures that the data presented directly supports the effectiveness of the product as formulated.

The unique challenge in quantifying the product’s impact lies in its dual-action formula. Stemregen includes both stem cell mobilizers that increase circulating stem cells and agents that encourage these cells to migrate into tissues. If the stem cells are simultaneously released and directed to tissues, blood tests may show no increase in stem cell count even when significant tissue benefits occur. Therefore, the speaker explains, the true efficacy of Stemregen must be evaluated through models of tissue repair rather than simple blood measurements.

To demonstrate this, Stemregen is being studied in human trials rather than animal models. One ongoing study focuses on chronic stable congestive heart failure. In this six-month trial, participants take two capsules of Stemregen three times a day. Preliminary results from ten patients have shown remarkable outcomes: all participants regained normal heart function after six months, underscoring the potential of stem cells to aid in heart tissue repair. This isn't about treating diseases directly; it’s about highlighting the body's capacity to repair when more stem cells are available.

Another study is exploring the effects of Stemregen on Parkinson’s disease. Although early, with four participants completing three months of the protocol, initial data shows promising improvements, suggesting that stem cells can enter the brain and assist in neural repair. Additional research plans are underway for emphysema, COPD, liver issues, systemic inflammation, and ulcerative colitis. Future studies will also involve animal models to clarify the mechanisms at play, illustrating how stem cells contribute to observed improvements in various organs.

The speaker emphasizes that the primary takeaway is not a claim of curing diseases but a demonstration of what the body can achieve when its own stem cell reserves are enhanced. Stemregen, by mobilizing and directing a person's own stem cells, essentially restores the body's innate repair power, which declines with age. This concept echoes the fundamental insights from Cracking the Stem Cell Code, reinforcing the idea that maintaining a robust supply of stem cells is crucial for tissue maintenance and overall well-being.